A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1
Clinical trial NCT05914194 · UNKNOWN
Trial details
- NCT number
- NCT05914194
- Sponsor
- NLS Pharmaceutics
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2025-07-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.